Sci-Tech Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.

Press releases published on September 28, 2026

Currus Biologics announces FDA IND clearance for Phase 1 trial of CUR-001 in mesothelin-positive advanced refractory solid tumours
Propow Is Most Likely the Golf Cart Lithium Battery Supplier Behind Bolt Energy
Crusoe Developing Data Center Campus in Armstrong County, Texas
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
World Tourism Day: ANCEL Reminds Road-Trippers to Prepare for the 'Next Start,' Not Just the Miles Ahead
Milestone Systems ranked number one in combined video management software and cloud-based security market in EMEA
Aberdeen Announces 2026 AGM Results
Conseleo Appoints Two Senior Board Figures as Advisors Ahead of November Launch
KingSmith WalkingPad’s Foldable Fitness Innovations Receive an Enthusiastic Response at IFA 2026
Zayed Sustainability Prize Unveils 2027 Finalists Following Record-Breaking Global Entry
IDT Corporation Reports Record Fourth Quarter and Fiscal Year 2026 Results
Waldencast plc Announces First Half 2026 Financial Results
Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
Anant Ambani-Led Kutch Renewable Hub Projected to Avoid 29 Million Tonnes of CO2 a Year, Analysis Finds
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
Applied Digital Sets Fiscal First Quarter 2027 Conference Call for Wednesday, October 7, 2026, at 5:00 p.m. Eastern Time
yul.io Introduces Collaborative Group Video Gifts for Birthdays and Milestones
UN Global Council of Change Taps CYPFER to Strengthen Cyber Resilience Across Global Leadership Initiatives
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.